Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Novartis Ag ADR
(NY:
NVS
)
96.16
-3.30 (-3.32%)
Official Closing Price
Updated: 7:00 PM EDT, Oct 4, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,088,955
Open
96.22
Bid (Size)
92.58 (1)
Ask (Size)
105.00 (1)
Prev. Close
99.46
Today's Range
94.93 - 96.41
52wk Range
74.24 - 105.61
Shares Outstanding
N/A
Dividend Yield
3.61%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Why Cal-Maine Foods Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Today 12:48 EDT
Gainers Gaucho Group Holdings, Inc. (NASDAQ: VINO) jumped 95.2% to $3.7280. Gaucho Group is planning to list two of its retail properties in Argentina, in San Rafael and Cordoba, for sale, priced at $2...
Via
Benzinga
Novartis Shares Decline As Spin Off Sandoz's Market Debut Falls Short of Expected Valuation
Today 12:35 EDT
Sandoz Group AG (OTC: SDZNY) (OTC: SDZXF) enters a new era as a standalone player in generic and biosimilar medicines.
Via
Benzinga
Performance
YTD
+4.28%
+4.28%
1 Month
-1.97%
-1.97%
3 Month
-2.82%
-2.82%
6 Month
+1.15%
+1.15%
1 Year
+22.92%
+22.92%
More News
Read More
SDZNY Stock: 7 Things to Know as Novartis Spinoff Sandoz Starts Trading Today
Today 11:33 EDT
Via
InvestorPlace
Cancer Drug Maker 3D Medicines Inc. Trading Higher After Company Announces It Will Repurchase Up To 10% Of Outstanding Shares
Today 9:49 EDT
Via
Benzinga
Cal-Maine Foods, A10 Networks And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Today 6:08 EDT
Via
Benzinga
Novartis Mulls Divesting Some Assets Of Radiopharma Unit In Strategic Shift
October 03, 2023
Via
Benzinga
Drugmakers Agree To Participate For Medicare Drug Price Negotiation With Biden Administration
October 03, 2023
Via
Benzinga
Novartis' Investigational Therapy Shows Promising Action In Rare Kidney Disease
October 02, 2023
Via
Benzinga
Cardiol Therapeutics 76% YTD Gain Is A Bullish Signal Ahead Of Expected Phase III Trial Announcements ($CRDL)
October 02, 2023
Via
AB Newswire
Topics
Death
Exposures
Death
Product Safety
Fusion Pharmaceuticals Poised For Leadership In Targeted Cancer Therapies: Oppenheimer
September 29, 2023
Via
Benzinga
Allakos' Antibodies For Chronic Skin Conditions, Analyst Sees Over 400% Stock Upside
September 27, 2023
Via
Benzinga
Ionis-Roche Join Forces To Compete In Neurodegenerative Disease Space, Analyst Sees Short-Term Challenges
September 27, 2023
Via
Benzinga
Health Insurer Centene Streamlines - Plans Massive Layoffs To Cut Costs: Report
September 27, 2023
Via
Benzinga
Topics
Workforce
Exposures
Layoff
Benzinga's Top Ratings Upgrades, Downgrades For September 25, 2023
September 25, 2023
Via
Benzinga
Amazon Invests $4B In ChatGPT Competitor, Hollywood Writers Accept Tentative Deal, ChatGPT Challenges Siri And Alexa With Introduction Of Verbal Responses: Today's Top Stories
September 25, 2023
Via
Benzinga
Novartis Sandoz Prepares For Public Debut With Strong Sales Record And Plans for New Biologic Drugs
September 25, 2023
Via
Benzinga
Are Gene Therapy Stocks The Market's Next Big Winners?
September 25, 2023
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Novartis Precision Cancer Therapy Hits Primary Goal In Rare Type Of Pancreatic Cancer
September 25, 2023
Via
Benzinga
Week In Review: Everest Acquires Novel Autoimmune Therapy In $132 Million Agreement
September 23, 2023
Via
Talk Markets
AI To Revolutionize Clinical Trials And Diagnostics
September 22, 2023
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
From Years to Months: How AI is Shaping the Landscape of Clinical Trials
September 22, 2023
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Preventable Vaccines Market May See a Big Move : AstraZeneca, GlaxoSmithKline, Merck
September 19, 2023
Via
SBWire
Amazon Poaches Microsoft's Product Chief, Google And DoD Team Up For AI-Powered Microscope To Identify Cancer, Rocket Lab's 41st Mission Succumbed To Technical Issues: Today's Top Stories
September 19, 2023
Via
Benzinga
Chinese Drugmaker BeiGene And Novartis Move Out From Second Cancer Drug Pact
September 19, 2023
Via
Benzinga
AMC Stock Alert: Adam Aron Teases New Chocolate, Wine Brands for AMC
September 15, 2023
Via
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.